Back to search
FDAFDA · Food and drugs·Recall number D-1178-2023

Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.

Published October 4, 2023 · Recall initiated: September 12, 2023

Summary

FDA records drug Class III recall D-1178-2023, published October 4, 2023 and initiated September 12, 2023. Recalling firm: Tolmar, Inc.; Status: Terminated; Reported quantity: 2990 cartons; Lot: Lot: 13635A1, Exp. 07/31/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

What to do

Voluntary: Firm initiated · Letter

Get an email if ELIGARD has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ELIGARD
Manufacturer
Tolmar, Inc.
Distributor
Nationwide in the US.
Lot
Lot: 13635A1, Exp. 07/31/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526. recalled?

Yes. FDA published recall D-1178-2023 on October 4, 2023. Reported hazard: Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ELIGARD.